{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:58:52Z","timestamp":1791104332021,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00415-011-5932-1","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T09:37:49Z","timestamp":1305020269000},"page":"323-327","source":"Crossref","is-referenced-by-count":12,"title":["Drug-induced impulse control disorders in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"258","author":[{"given":"J.","family":"Reiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"5932_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002018-200932060-00004","volume":"32","author":"A Antonini","year":"2009","unstructured":"Antonini A, Cilia R (2009) Behavioural adverse effects of dopaminergic treatments in Parkinson\u2019s disease: incidence, neurobiological basis, management and prevention. Drug Saf 32:475\u2013488","journal-title":"Drug Saf"},{"key":"5932_CR2","unstructured":"American Psychiatric Association (2000) APA diagnostic and statistical manual of mental disorders, 4th edn text revision. American Psychiatric Association, Washington, DC"},{"key":"5932_CR3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","volume":"21","author":"C Ardouin","year":"2006","unstructured":"Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, Pelissolo A, Moro E, Lhommee E, Lang AE, Agid Y, Benabid AL, Pollak P, Mallet L, Krack P (2006) Pathological gambling in Parkinson\u2019s disease improves on chronic subthalamic nucleus stimulation. Mov Disord 21:1941\u20131946","journal-title":"Mov Disord"},{"key":"5932_CR4","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","volume":"21","author":"M Avanzi","year":"2006","unstructured":"Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2006) Prevalence of pathological gambling in patients with Parkinson\u2019s disease. Mov Disord 21:2068\u20132072","journal-title":"Mov Disord"},{"key":"5932_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.parkreldis.2007.04.006","volume":"14","author":"M Avanzi","year":"2008","unstructured":"Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2008) The thrill of reckless driving in patients with Parkinson\u2019s disease: an additional behavioural phenomenon in dopamine dysregulation syndrome? Parkinsonism Relat Disord 14:257\u2013258","journal-title":"Parkinsonism Relat Disord"},{"key":"5932_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4065\/84.4.310","volume":"84","author":"JM Bostwick","year":"2009","unstructured":"Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (2009) Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 84:310\u2013316","journal-title":"Mayo Clin Proc"},{"key":"5932_CR7","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archneur.65.12.1604","volume":"65","author":"R Cilia","year":"2008","unstructured":"Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, Pezzoli G, Antonini A (2008) Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 65:1604\u20131611","journal-title":"Arch Neurol"},{"key":"5932_CR8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3932(03)00117-9","volume":"41","author":"R Cools","year":"2003","unstructured":"Cools R, Barker RA, Sahakian BJ, Robbins TW (2003) L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson\u2019s disease. Neuropsychologia 41:1431\u20131441","journal-title":"Neuropsychologia"},{"key":"5932_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.npp.1301153","volume":"32","author":"R Cools","year":"2007","unstructured":"Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW (2007) L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson\u2019s disease. Neuropsychopharmacology 32:180\u2013189","journal-title":"Neuropsychopharmacology"},{"key":"5932_CR10","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0028-3932(02)00108-2","volume":"40","author":"V Czernecki","year":"2002","unstructured":"Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B (2002) Motivation, reward, and Parkinson\u2019s disease: influence of dopatherapy. Neuropsychologia 40:2257\u20132267","journal-title":"Neuropsychologia"},{"key":"5932_CR11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neuron.2009.01.031","volume":"61","author":"A Dagher","year":"2009","unstructured":"Dagher A, Robbins TW (2009) Personality, addiction, dopamine: insights from Parkinson\u2019s disease. Neuron 61:502\u2013510","journal-title":"Neuron"},{"key":"5932_CR12","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/WNL.0b013e3181fc2898","volume":"75","author":"RB Dewey Jr","year":"2010","unstructured":"Dewey RB Jr (2010) Pathological gambling in PD: did the devil make me do it? Neurology 75:1668\u20131669","journal-title":"Neurology"},{"key":"5932_CR13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","volume":"62","author":"ML Dodd","year":"2005","unstructured":"Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377\u20131381","journal-title":"Arch Neurol"},{"key":"5932_CR14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mds.21303","volume":"22","author":"AH Evans","year":"2007","unstructured":"Evans AH, Butzkueven H (2007) Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord 22:590\u2013591","journal-title":"Mov Disord"},{"key":"5932_CR15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","volume":"65","author":"AH Evans","year":"2005","unstructured":"Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65:1570\u20131574","journal-title":"Neurology"},{"key":"5932_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.20822","volume":"59","author":"AH Evans","year":"2006","unstructured":"Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59:852\u2013858","journal-title":"Ann Neurol"},{"key":"5932_CR17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.22505","volume":"24","author":"AH Evans","year":"2009","unstructured":"Evans AH, Strafella AP, Weintraub D, Stacy M (2009) Impulsive and compulsive behaviors in Parkinson\u2019s disease. Mov Disord 24:1561\u20131570","journal-title":"Mov Disord"},{"key":"5932_CR18","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1126\/science.1102941","volume":"306","author":"MJ Frank","year":"2004","unstructured":"Frank MJ, Seeberger LC, O\u2019Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306:1940\u20131943","journal-title":"Science"},{"key":"5932_CR19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","volume":"22","author":"DA Gallagher","year":"2007","unstructured":"Gallagher DA, O\u2019Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson\u2019s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22:1757\u20131763","journal-title":"Mov Disord"},{"key":"5932_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5932_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/cercor\/bhg105","volume":"14","author":"IK Goerendt","year":"2004","unstructured":"Goerendt IK, Lawrence AD, Brooks DJ (2004) Reward processing in health and Parkinson\u2019s disease: neural organization and reorganization. Cereb Cortex 14:73\u201380","journal-title":"Cereb Cortex"},{"key":"5932_CR22","unstructured":"Grace AA (2000) The tonic\/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95 (Suppl 2):S119\u2013S128"},{"key":"5932_CR23","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/appi.ajp.162.11.2184","volume":"162","author":"JE Grant","year":"2005","unstructured":"Grant JE, Levine L, Kim D, Potenza MN (2005) Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162:2184\u20132188","journal-title":"Am J Psychiatry"},{"key":"5932_CR24","doi-asserted-by":"crossref","first-page":"13213","DOI":"10.1523\/JNEUROSCI.3446-06.2006","volume":"26","author":"AR Hariri","year":"2006","unstructured":"Hariri AR, Brown SM, Williamson DE, Flory JD, de Wit H, Manuck SB (2006) Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci 26:13213\u201313217","journal-title":"J Neurosci"},{"key":"5932_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mds.21872","volume":"23","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:411\u2013415","journal-title":"Mov Disord"},{"key":"5932_CR26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","volume":"162","author":"PW Kalivas","year":"2005","unstructured":"Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403\u20131413","journal-title":"Am J Psychiatry"},{"key":"5932_CR27","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1097\/00001756-200011270-00019","volume":"11","author":"G Kunig","year":"2000","unstructured":"Kunig G, Leenders KL, Martin-Solch C, Missimer J, Magyar S, Schultz W (2000) Reduced reward processing in the brains of parkinsonian patients. Neuroreport 11:3681\u20133687","journal-title":"Neuroreport"},{"key":"5932_CR28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0893-133X(02)00366-4","volume":"27","author":"M Leyton","year":"2002","unstructured":"Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A (2002) Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET\/[11C]raclopride study in healthy men. Neuropsychopharmacology 27:1027\u20131035","journal-title":"Neuropsychopharmacology"},{"key":"5932_CR29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","volume":"16","author":"SY Lim","year":"2009","unstructured":"Lim SY, O\u2019Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, Lees AJ, O\u2019Sullivan DJ, Peppard RF, Rodrigues JP, Schrag A, Silberstein P, Tisch S, Evans AH (2009) Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson\u2019s disease. J Clin Neurosci 16:1148\u20131152","journal-title":"J Clin Neurosci"},{"key":"5932_CR30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archneur.63.2.298-a","volume":"63","author":"C Lu","year":"2006","unstructured":"Lu C, Bharmal A, Suchowersky O (2006) Gambling and Parkinson disease. Arch Neurol 63:298","journal-title":"Arch Neurol"},{"key":"5932_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"E Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D (2008) Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:75\u201380","journal-title":"Mov Disord"},{"key":"5932_CR32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","volume":"23","author":"SS O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan SS, Evans AH, Lees AJ (2009) Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 23:157\u2013170","journal-title":"CNS Drugs"},{"key":"5932_CR33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","volume":"67","author":"G Pontone","year":"2006","unstructured":"Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67:1258\u20131261","journal-title":"Neurology"},{"key":"5932_CR34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/155005941004100208","volume":"41","author":"N Ray","year":"2010","unstructured":"Ray N, Strafella AP (2010) Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson\u2019s disease: insights from functional imaging. Clin EEG Neurosci 41:87\u201393","journal-title":"Clin EEG Neurosci"},{"key":"5932_CR35","first-page":"203","volume":"75","author":"G Rylander","year":"1972","unstructured":"Rylander G (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75:203\u2013212","journal-title":"Psychiatr Neurol Neurochir"},{"key":"5932_CR36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","volume":"89","author":"HJ Shaffer","year":"1999","unstructured":"Shaffer HJ, Hall MN, Vander Bilt J (1999) Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 89:1369\u20131376","journal-title":"Am J Public Health"},{"key":"5932_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00415-009-5301-5","volume":"257","author":"C Siri","year":"2010","unstructured":"Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, Pezzoli G, Antonini A (2010) Cognitive status of patients with Parkinson\u2019s disease and pathological gambling. J Neurol 257:247\u2013252","journal-title":"J Neurol"},{"key":"5932_CR38","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C]raclopride PET study. Brain 132:1376\u20131385","journal-title":"Brain"},{"key":"5932_CR39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","volume":"68","author":"A Thomas","year":"2010","unstructured":"Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 68:400\u2013404","journal-title":"Ann Neurol"},{"key":"5932_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","volume":"68","author":"M Tippmann-Peikert","year":"2007","unstructured":"Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH (2007) Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68:301\u2013303","journal-title":"Neurology"},{"key":"5932_CR41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","volume":"75","author":"T Eimeren van","year":"2010","unstructured":"van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP (2010) Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75:1711\u20131716","journal-title":"Neurology"},{"key":"5932_CR42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.22453","volume":"24","author":"D Verbaan","year":"2009","unstructured":"Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ (2009) Psychotic and compulsive symptoms in Parkinson\u2019s disease. Mov Disord 24:738\u2013744","journal-title":"Mov Disord"},{"key":"5932_CR43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254\u20131257","journal-title":"Neurology"},{"key":"5932_CR44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212\u2013216","journal-title":"Arch Neurol"},{"key":"5932_CR45","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord 24:1461\u20131467","journal-title":"Mov Disord"},{"key":"5932_CR46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3,090 patients. Arch Neurol 67:589\u2013595","journal-title":"Arch Neurol"},{"issue":"5","key":"5932_CR47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00415-008-5010-5","volume":"255","author":"E Wolters","year":"2008","unstructured":"Wolters E, van der Werf YD, van den Heuvel OA (2008) Parkinson\u2019s disease-related disorders in the impulsive-compulsive spectrum. J Neurol 255(5):48\u201356","journal-title":"J Neurol"},{"key":"5932_CR48","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/pgmj.2008.075820","volume":"85","author":"K Wu","year":"2009","unstructured":"Wu K, Politis M, Piccini P (2009) Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J 85:590\u2013596","journal-title":"Postgrad Med J"},{"key":"5932_CR49","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.0b013e3181d55f24","volume":"74","author":"TA Zesiewicz","year":"2010","unstructured":"Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:924\u2013931","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5932-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-5932-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5932-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:13:05Z","timestamp":1559056385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-5932-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["5932"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-5932-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}